James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Twitter Inc (TWTR) Stock Won’t Be Any Better Off After Pruning Vine

On the surface, TWTR stock looks like it's finally on track. The Vine flop, however, reminds that Twitter is still grasping at straws.

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t on Earnings Alert

Valeant Pharmaceuticals (VRX) is down more than 90% since mid-2015. The upside? One quarter won't make or break VRX stock now.

Why Activision Blizzard, Inc. (ATVI), First Solar, Inc. (FSLR) and Symantec Corporation (SYMC) are 3 of Today’s Worst Stocks

Symantec (SYMC), First Solar (FSLR) and Activision Blizzard (ATVI) were each suspiciously omitted from Friday's rally.

7 Large-Cap Stocks That Will Ruin Your Retirement

These large-cap stocks are found in a lot of retirement portfolios, but they're not the long-term no-brainers that they're cracked up to be.

The Real Reason General Electric Company (GE) Bought Baker Hughes

If GE stock is to become a truly great investment again, General Electric has to prove something -- using Baker Hughes as evidence.